Sensorimotor Training With a Mobilized Balance Platform in Patients With Chronic Low Back Pain
16 mai 2026 mis à jour par: Sefa Gümrük Aslan, Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Effects of a Sensorimotor Training Protocol Using a Mobilized Balance Platform on Proprioceptive System, Movement Control, and Quality of Life in Patients With Chronic Low Back Pain
This randomized controlled study aims to investigate the effects of a sensorimotor training protocol using a mobilized balance platform device on proprioceptive system function, movement control, balance, physical performance, pain severity, and quality of life in patients with chronic low back pain. A total of 44 patients with chronic low back pain will be recruited from the outpatient clinic of Gaziler Physical Medicine and Rehabilitation Training and Research Hospital.
Participants will be randomly assigned to either a sensorimotor training group or a control group. The intervention group will receive sensorimotor training using the Huber 360 balance system, while the control group will perform a home exercise program including stretching, spinal mobility, lumbopelvic control, and balance exercises.
Pain severity, proprioception, functional status, balance, physical performance, and quality of life will be assessed before and after treatment by an assessor blinded to group allocation.
Aperçu de l'étude
Statut
Recrutement
Les conditions
Intervention / Traitement
Type d'étude
Interventionnel
Inscription (Estimé)
44
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Coordonnées de l'étude
- Nom: Sefa Gumruk Aslan
- Numéro de téléphone: +903122911503
- E-mail: sefagumrukk@gmail.com
Lieux d'étude
-
-
-
Ankara, Turquie (Türkiye)
- Recrutement
- Ankara Gaziler physical therapy and rehabilitation hospital
-
Contact:
- Sefa Gumruk Aslan
- Numéro de téléphone: +903122911503
- E-mail: sefagumrukk@gmail.com
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
Non
La description
Inclusion Criteria:
- Individuals aged between 18 and 55 years
- Presence of chronic low back pain lasting at least 3 months
- Pain intensity score of 3 or higher on the Visual Analog Scale (VAS)
- Individuals with sufficient cognitive ability to understand and follow study procedures
- Willingness to participate voluntarily in the study
Exclusion Criteria:
- Participation in a similar training program within the last 12 months
- History of lower extremity or spinal surgery
- Presence of non-mechanical low back pain, inflammatory disease, or tumor
- Uncontrolled hypertension or cardiac disease
- History of malignancy
- Presence of radicular symptoms associated with low back pain
- Progressive neurological deficits
- Neurogenic claudication
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Home Exercise Program
Participants in this group will perform a home exercise program including warm-up and stretching exercises, spinal mobility exercises, lumbopelvic control exercises, and balance exercises.
The program will be performed for 30 minutes per session, twice weekly for 5 weeks.
|
Participants will perform a home exercise program including warm-up and stretching exercises, spinal mobility exercises, lumbopelvic control exercises, and balance exercises.
The program will be performed for 30 minutes per session, twice weekly for 5 weeks.
|
|
Expérimental: Huber 360 Sensorimotor Training
Participants in this group will receive a sensorimotor training protocol using the Huber 360 balance system.
The intervention will include progressive rotational and oscillatory exercises aimed at improving proprioception, balance, neuromuscular control, and movement control.
Sessions will be performed for 30 minutes, twice weekly for 5 weeks.
|
Participants will perform a home exercise program including warm-up and stretching exercises, spinal mobility exercises, lumbopelvic control exercises, and balance exercises.
The program will be performed for 30 minutes per session, twice weekly for 5 weeks.
Participants will receive sensorimotor training using the Huber 360 balance system.
The protocol will include progressive rotational and oscillatory exercises designed to improve proprioception, balance, neuromuscular control, and movement control in patients with chronic low back pain.
Sessions will be performed for 30 minutes, twice weekly for 5 weeks.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Lumbar Proprioception Assessment
Délai: Before treatment and immediately after completion of the 5-week intervention program
|
Lumbar proprioception will be assessed using lumbar repositioning tests at 60 degrees flexion and 15 degrees extension.
Participants will be asked to reproduce target lumbar positions, and the angular repositioning error will be recorded.
Lower repositioning error values indicate better lumbar proprioceptive accuracy.
|
Before treatment and immediately after completion of the 5-week intervention program
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Pain Severity Assessed by Visual Analog Scale
Délai: Before treatment and immediately after completion of the 5-week intervention program
|
Pain intensity will be assessed using a 10-cm Visual Analog Scale (VAS).
Scores range from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain.
Higher scores indicate greater pain severity.
|
Before treatment and immediately after completion of the 5-week intervention program
|
|
Functional Status Assessed by Oswestry Disability Index
Délai: Before treatment and immediately after completion of the 5-week intervention program
|
Functional disability related to low back pain will be assessed using the Oswestry Disability Index (ODI).
Higher scores indicate greater disability.
|
Before treatment and immediately after completion of the 5-week intervention program
|
|
Balance and Limits of Stability Assessed by Huber 360
Délai: Before treatment and immediately after completion of the 5-week intervention program
|
Static balance, dynamic balance, and limits of stability will be assessed using the Huber 360 balance system.
Better balance performance and improved stability limits indicate better postural control.
|
Before treatment and immediately after completion of the 5-week intervention program
|
|
Lumbar Flexion Range of Motion
Délai: Before treatment and immediately after completion of the 5-week intervention program
|
Physical performance will be assessed using a Physical Performance Test Battery including lumbar flexion range of motion, 50-step walking test, 5-minute walking test, five-repetition sit-to-stand test, ten-repetition trunk flexion test, and forward reaching with weight.
|
Before treatment and immediately after completion of the 5-week intervention program
|
|
Quality of Life Assessed by Short Form-36
Délai: Before treatment and immediately after completion of the 5-week intervention program
|
Quality of life will be assessed using the Short Form-36 (SF-36).
Higher scores indicate better health-related quality of life.
|
Before treatment and immediately after completion of the 5-week intervention program
|
|
50-Step Walking Test
Délai: Before treatment and immediately after completion of the 5-week intervention program
|
he time required to complete the 50-step walking test will be recorded in seconds
|
Before treatment and immediately after completion of the 5-week intervention program
|
|
Five-Minute Walking Test
Délai: Before treatment and immediately after completion of the 5-week intervention program
|
The time required to complete five sit-to-stand repetitions will be recorded in seconds.
|
Before treatment and immediately after completion of the 5-week intervention program
|
|
Ten-Repetition Trunk Flexion Test
Délai: Before treatment and immediately after completion of the 5-week intervention program
|
The time required to complete ten trunk flexion repetitions will be recorded in seconds.
|
Before treatment and immediately after completion of the 5-week intervention program
|
|
Forward Reaching with Weight Test
Délai: Before treatment and immediately after completion of the 5-week intervention program
|
Forward reaching distance while holding weight will be measured in centimeters.
|
Before treatment and immediately after completion of the 5-week intervention program
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
4 mai 2026
Achèvement primaire (Estimé)
30 octobre 2026
Achèvement de l'étude (Estimé)
30 novembre 2026
Dates d'inscription aux études
Première soumission
3 mai 2026
Première soumission répondant aux critères de contrôle qualité
16 mai 2026
Première publication (Réel)
22 mai 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
22 mai 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
16 mai 2026
Dernière vérification
1 mai 2026
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- CLBP-MBP-2026
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
NON
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .